Compare ALEMBIC PHARMA with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs DR. DATSONS LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA DR. DATSONS LABS ALEMBIC PHARMA/
DR. DATSONS LABS
 
P/E (TTM) x 17.5 -10.9 - View Chart
P/BV x 6.9 0.2 4,272.8% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 ALEMBIC PHARMA   DR. DATSONS LABS
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
DR. DATSONS LABS
Mar-14
ALEMBIC PHARMA/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs664126 528.7%   
Low Rs41231 1,334.6%   
Sales per share (Unadj.) Rs208.7133.0 156.9%  
Earnings per share (Unadj.) Rs31.00.2 20,445.6%  
Cash flow per share (Unadj.) Rs37.16.6 561.6%  
Dividends per share (Unadj.) Rs5.500-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs144.2128.8 112.0%  
Shares outstanding (eoy) m188.5231.66 595.5%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x2.60.6 438.3%   
Avg P/E ratio x17.4516.1 3.4%  
P/CF ratio (eoy) x14.511.8 122.5%  
Price / Book Value ratio x3.70.6 614.2%  
Dividend payout %17.70-   
Avg Mkt Cap Rs m101,4612,477 4,095.5%   
No. of employees `000NANA-   
Total wages/salary Rs m7,46756 13,333.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m39,3474,211 934.5%  
Other income Rs m9479 119.2%   
Total revenues Rs m39,4414,289 919.5%   
Gross profit Rs m8,736569 1,536.4%  
Depreciation Rs m1,152204 563.7%   
Interest Rs m184430 42.8%   
Profit before tax Rs m7,49313 59,001.6%   
Minority Interest Rs m110-   
Prior Period Items Rs m-93-2 5,155.6%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5686 25,696.7%   
Profit after tax Rs m5,8445 121,743.8%  
Gross profit margin %22.213.5 164.4%  
Effective tax rate %20.948.0 43.6%   
Net profit margin %14.90.1 13,027.8%  
BALANCE SHEET DATA
Current assets Rs m19,5776,852 285.7%   
Current liabilities Rs m14,8966,711 222.0%   
Net working cap to sales %11.93.3 355.3%  
Current ratio x1.31.0 128.7%  
Inventory Days Days90161 55.8%  
Debtors Days Days45318 14.2%  
Net fixed assets Rs m27,0973,673 737.7%   
Share capital Rs m377317 119.1%   
"Free" reserves Rs m26,8113,761 712.9%   
Net worth Rs m27,1884,078 666.8%   
Long term debt Rs m4,9931,671 298.8%   
Total assets Rs m47,77812,633 378.2%  
Interest coverage x41.71.0 4,050.6%   
Debt to equity ratio x0.20.4 44.8%  
Sales to assets ratio x0.80.3 247.1%   
Return on assets %12.63.4 366.4%  
Return on equity %21.50.1 18,258.3%  
Return on capital %23.67.7 307.6%  
Exports to sales %022.9 0.0%   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNA964 0.0%   
Imports (cif) Rs mNA602 0.0%   
Fx inflow Rs m19,453964 2,017.9%   
Fx outflow Rs m6,065607 999.0%   
Net fx Rs m13,388357 3,751.2%   
CASH FLOW
From Operations Rs m8,1201,345 603.8%  
From Investments Rs m-7,556-2,256 335.0%  
From Financial Activity Rs m590-1,200 -49.2%  
Net Cashflow Rs m1,153-2,111 -54.6%  

Share Holding

Indian Promoters % 74.1 4.5 1,635.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 0.0 -  
FIIs % 9.1 1.4 674.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 94.1 14.8%  
Shareholders   49,328 20,807 237.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   DR. REDDYS LAB  STERLING BIOTECH  ASTRAZENECA PHARMA  SUN PHARMA  IPCA LABS  

Compare ALEMBIC PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On...(Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Apr 16, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS